am PW, Adkins RB, Dean RH. Phlegmasia cerulea
dolens: therapeutic considerations. South Med J 1988;81:306-12.
53. Qvarfordt P, Ekl√∂f B, Ohlin P. Intramuscular pressure in the lower leg
in deep vein thrombosis and phlegmasia cerulae dolens. Ann Surg
1983;197:450-3.
54. Gloviczki P, Hollier LH, Cherry KJ, Pairolero PC, Gale SS, Schirger A.
Phlegmaisa cerulea dolens: the continuing morbidity. Int Angiol
1982;1:127-34.
55. Fogarty TJ, Cranley JJ, Krause RJ, Strasser ES, Hafner CD. Surgical
management of phlegmasia cerulea dolens. Arch Surg 1963;86:256-63.
56. Lorimer JW, Semelhago LC, Barber GG. Venous gangrene of the
extremities. Can J Surg 1994;37:379-84.
57. Hood DB, Weaver FA, Modrall JG, Yellin AE. Advances in the
treatment of phlegmasia cerulea dolens. Am J Surg 1993;166:206-10.
58. Warkentin TE. Venous limb gangrene during warfarin treatment of
cancer-associated deep venous thrombosis. Ann Intern Med 2001;
135:589-93.
59. Warkentin TE, Elavathil LJ, Hayward CP, Johnston MA, Russett
JI, Kelton JG. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med
1997;127:804-12.
60. Linkins LA, Warkentin TE. The approach to heparin-induced thrombocytopenia. Semin Respir Crit Care Med 2008;29:66-74.
61